Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
- 13 October 2023
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 45 (12) , 3086-3095
Abstract
Background: This study analyzed the predictive value of artificial intelligence (AI)‐powered tumor‐infiltrating lymphocyte (TIL) analysis in recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC) treated with axitinib.Methods: Patients from a multicenter, prospective phase II trial evaluating axitinib efficacy in R/M ACC were included in this study. H&E whole‐side images of archival tumor tissues were analyzed by Lunit SCOPE IO, an AI‐powered spatial TIL analyzer.Results: Twenty‐seven patients were included in the analysis. The best response was stable disease, and the median progression‐free survival (PFS) was 11.1 months (95% CI, 9.2–13.7 months). Median TIL densities in the cancer and surrounding stroma were 25.8/mm2 (IQR, 8.3–73.0) and 180.4/mm2 (IQR, 69.6–342.8), respectively. Patients with stromal TIL density >342.5/mm2 exhibited longer PFS (p = 0.012).Conclusions: Cancer and stromal area TIL infiltration were generally low in R/M ACC. Higher stromal TIL infiltration was associated with a longer PFS with axitinib treatment.Keywords
Funding Information
- AstraZeneca
- MSD
- Ono Pharmaceutical
This publication has 29 references indexed in Scilit:
- Immunomodulatory Activity of VEGF in Cancer2017
- A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaAnnals of Oncology, 2016
- Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinomaCancer, 2015
- Whole exome sequencing of adenoid cystic carcinomaJournal of Clinical Investigation, 2013
- A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACCAnnals of Oncology, 2011
- Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A reviewHead & Neck, 2011
- Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic SignificanceClinical Cancer Research, 2010
- Salivary gland adenoid cystic carcinoma: A review of chemotherapy and molecular therapiesOral Oncology, 2006
- Expressions of Nuclear Factor κB, Inducible Nitric Oxide Synthase, and Vascular Endothelial Growth Factor in Adenoid Cystic Carcinoma of Salivary Glands: Correlations with the Angiogenesis and Clinical OutcomeClinical Cancer Research, 2005
- Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centreBritish Journal of Surgery, 1996